Navigation Links
Surgical Theater, LLC sells first Surgical Rehearsal Platform to UH Case Medical Center
Date:11/28/2012

Surgical Theater, LLC, creator of the Selman Surgical Rehearsal Platform (SRP), has made the first sale of its groundbreaking technology to University Hospitals (UH) Case Medical Center in Cleveland, one of the most respected research/teaching hospitals in America. Physicians at the medical center have been instrumental in the development of Surgical Theater, so it is fitting that the institution becomes the first to own the unique, 3D imaging rehearsal platform.

Using standard scanned images from any patient, the SRP generates 3D patient specific and accurate models of interactions between life-like tissue and surgical instruments. The tissue responds "realistically" to actions taken by the surgeon, thus allowing accurate pre-surgery planning and rehearsal. The unique software utilizes flight simulator technology to permit remote connection of multiple SRPs; participants anywhere in the world can simultaneously work together and practice the same case with real-time feedback and collaborate on the planning of a specific surgery case.

Dr. Warren Selman, Chairman, Department of Neurological Surgery at UH Case Medical Center and Case Western Reserve University School of Medicine in Cleveland, is a co-originator of the Platform's development. Not long ago, a random conversation at a coffee shop between Dr. Selman and the now-CEO of Surgical Theater was the beginning of the SRP's development.

"We're thrilled to have our first sale be to the institution that has been our partner in developing the SRP. The innovative spirit and trailblazing research in this academic medical center have inspired us from the inception of Surgical Theater," said Moty Avisar, President and CEO, Surgical Theater.

The Neurological Surgery Department at UH Case Medical Center has been using the SRP for over two years, and provided clinical insight to the company during its development. Now, with the purchase of the Platform, it will be used for clinical studies to document the value of pre-surgical rehearsal, and for resident and fellow education. Following US Food and Drug Administration (FDA) approval, anticipated in the first quarter of next year, the Platform will be extended to routine patient care.

"Having been involved with the creation of this new technology, I've seen first-hand the potential for it to radically change neurosurgical training and benefit patient care. I'm thrilled that with the purchase by UH our physicians and neurosurgery residents will benefit first from the innovation," said Dr. Selman, who is also Neurosurgeon-in-Chief at University Hospitals and the Harvey Huntington Brown Jr., Professor at Case Western Reserve University School of Medicine.

Surgical Theater launched the Platform at the Congress of Neurological Surgeons Annual Meeting in early October after receiving their first broad patent approval and submitting their application to the FDA.

"To have our first sale so quickly after launch, and with the forecast of more than five additional sales in coming months, is gratifying after so many months of hard work," said Avisar. "We're excited first and foremost at the potential for improved patient outcomes, and at the same time anticipate this sale is the beginning of great things for our company."

Peter R. Brumbergs Named CFO

Along with the initial sale and the patent approval, interest in the company has emerged from a number of investors. To help manage these investment opportunities as well as company finances, Surgical Theater recently named Peter R. Brumbergs as its first Chief Financial Officer. Brumbergs is a savvy business leader with more than 35 years of experience at Fortune 500, middle-market and entrepreneurial companies.

Most recently Brumbergs was CFO of U.S. Endoscopy, a medical device manufacturer with world-wide distribution, and was a member of the executive team that led and closed the sale of U.S. Endoscopy to Steris Corporation. He was also instrumental in developing and implementing growth initiatives that resulted in sales quadrupling and operating income increasing by over 40 times.

"We are pleased to welcome Peter to our growing team of business and technology experts," Avisar said. "Peter's business savvy and national contacts in the medical equipment industry will be extremely important as we continue to grow."


'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Related biology news :

1. Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows
2. Researchers discover non-surgical test for brain cancer
3. Pre-surgical steps for eye surgery are standardized through JoVEs video publication
4. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
5. Research reveals first evidence of hunting by prehistoric Ohioans
6. First model of how buds grow into leaves
7. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
8. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
9. First complete full genetic map of promising energy crop
10. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
11. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... the thousands of attendees at this year,s International Consumer Electronics Show (CES), ... measurement devices and services, will be featuring its new line of ULTRA ... special CES Exhibit Suite , the new upper arm and wrist ... WellnessConnected product platform.  Continue Reading ... ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
(Date:12/22/2016)... 2016 SuperCom (NASDAQ:   ... the e-Government, Public Safety, HealthCare, and Finance sectors announced today that ... selected to implement and deploy a community-based supportive services program to ... , further expanding its presence in the state. ... This new program, which is ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... --  Boston Biomedical , an industry leader in the ... pathways, today presented data from two clinical studies for ... Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in ... In a Phase Ib/II study of napabucasin – an ... pathways by targeting STAT3 – colorectal cancer (CRC) patients ...
(Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... announced the formation of its Medical/Clinical Advisory Board. ... industry veterans who enhance the range and depth ... development of its novel prenatal diagnostic tests.  These ... and strategic guidance for the company,s product development ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers and ... is a fully 21 CFR Part 11-compliant email client designed to provide product ...
Breaking Biology Technology: